Hospira Recalls 0.9% Sodium Chloride Injection Due to Sterility Concerns
Hospira is recalling 314,600 bags of 0.9% Sodium Chloride Injection USP due to potential channel leaks that may compromise sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for drug recalls involving potential sterility issues.
Plain-English summary
Hospira Inc. is recalling 314,600 bags of 0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, NDC 00409-7101-68. The recall affects lots 49-084-JT and 49-119-JT, which were distributed in the United States.
The recall was initiated due to a lack of assurance of sterility. The source text identifies potential channel leaks near the threaded vial port as the cause of this defect.
Healthcare providers and patients should stop using the affected product and contact Hospira Inc. for further instructions or replacement.
The recalled product
- Product
- 0.9% Sodium Chloride Injection USP, 50 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira, Inc., Ausitn, TX 78728, NDC 00409-7101-68
- Manufacturer
- Hospira Inc.
- Category
- Drug — IV Fluid
- Hazard
- Affected units
- 314,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 49-084-JT
- 49-119-JT
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29